本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

4.68
-0.0800-1.68%
盤後4.900.2200+4.70%19:56 EDT
成交量:52.89萬
成交額:246.17萬
市值:3.20億
市盈率:-2.12
高:4.88
開:4.78
低:4.52
收:4.76
資料載入中...
2021/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/09

重要事件披露

8-K - Current report
2021/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/11

重要事件披露

8-K - Current report
2021/04/06

重要事件披露

8-K - Current report
2021/03/17

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/17

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/17

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/23

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/23

重要事件披露

8-K - Current report
2020/11/20

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/19

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/16

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/30

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933